Alex Zhavoronkov

Founder and CEO

Founder and CEO of Insilico Medicine, a leading global company in using artificial intelligence for drug discovery, headquartered in Hong Kong. He has published extensively in aging research and generative deep learning applied to medicine, and Insilico is among the first companies to advance drugs developed entirely by AI into clinical trial stages.